Having successfully sidestepped the first Covid wave, the government now faces a health emergency — only about 1% of its population is vaccinated so far — with the potential to disrupt the chip industry that dominates the local economy, and which is critical to an already-squeezed global supply.
Faced with a limited supply of shots, more countries are turning to an initially controversial strategy that’s now been vindicated by scientific studies: doubling or tripling the intervals between the first and second Covid vaccine dose.
Differences in infectious substance classifications, packaging requirements and other shipping regulations between countries create significant supply-chain challenges — particularly when it comes to sourcing approved packaging for shipping COVID-19 samples in Southeast Asia.
For months, developed economies have hoarded COVID-19 vaccines and the raw materials needed to make them. Now, they’re being forced to act as an explosive outbreak in India raises the risk of new virus mutations that could threaten the wider world.
President Biden far surpassed his original goal of administering 100 million doses of the COVID-19 vaccines within his first 100 days in office, but the initiative couldn’t have succeeded without a substantial manufacturing and logistics infrastructure backing it up.
The latest supply-chain news, analysis, trends and tools for executives in the healthcare industry. Learn how healthcare companies and their suppliers around the world are managing the flow of products across all channels of the enterprise. Experts sound off on forecasting and demand planning, supply-chain visibility, logistics outsourcing, inventory optimization, transportation management, warehouse management, supply-chain security, corporate social responsibility and more.
Wake up to live “Supply Chains in Crisis” updates and the latest Supply Chain News!
Subscribe to our Daily Newsletter
Timely, incisive articles delivered directly to your inbox.